Prescriptions of homeopathic remedies at the expense of the German statutory health insurance from 1985 to 2021: scientific, legal and pharmacoeconomic analysis
Hauke Leemhuis, Roland Seifert
When public health insurance pays for a treatment, the question is not only whether people want it. It is whether the evidence, the price, and the safety information justify using everyone’s shared money. Germany’s statutory health insurance spent millions on homeopathic and anthroposophical remedies, even as the evidence base remained weak. This study asks what happened to the costs, the claims, and the legal standards over time.